Investigation of lactotransferrin messenger RNA expression levels as an anti–type 2 asthma biomarker
Journal of Allergy and Clinical Immunology · 2024
DOI: 10.1016/j.jaci.2024.05.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024. Verfasst von Nicholas C Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona Internship, Basis Tucson North, Tucson, Ariz. Hauptthemen laut MEDLINE: Asthma, Lactoferrin, Biomarkers, RNA, Messenger. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Lactotransferrin (LTF) has an immunomodulatory function, and its expression levels are associated with asthma susceptibility. OBJECTIVES: We sought to investigate LTF messenger RNA (mRNA) expression levels in human bronchial epithelial cells (BECs) as an anti-type 2 (T2) asthma biomarker. METHODS: Association analyses between LTF mRNA expression levels in BECs and asthma-related phenotypes were performed in the Severe Asthma Research Program (SARP) cross-sectional (n = 155) and longitudinal (n = 156) cohorts using a generalized linear model. Correlation analyses of mRNA expression levels between LTF and all other genes were performed by Spearman correlation. RESULTS: Low LTF mRNA expression levels were associated with asthma susceptibility and severity (P < .025), retrospective and prospective asthma exacerbations, and low lung function (P < 8.3 × 10-3). Low LTF mRNA expression levels were associated with high airway T2 inflammation biomarkers (sputum eosinophils and fractional exhaled nitric oxide; P < 8.3 × 10-3) but were not associated with blood eosinophils or total serum IgE. LTF mRNA expression levels were negatively correlated with expression levels of TH2 or asthma-associated genes (POSTN, NOS2, and MUC5AC) and eosinophil-related genes (IL1RL1, CCL26, and IKZF2) and positively correlated with expression levels of TH1 and inflammation genes (IL12A, MUC5B, and CC16) and TH17-driven cytokines or chemokines for neutrophils (CXCL1, CXCL6, and CSF3) (P < 3.5 × 10-6). CONCLUSIONS: Low LTF mRNA expression levels in BECs are associated with asthma susceptibility, severity, and exacerbations through upregulation of airway T2 inflammation. LTF is a potential anti-T2 biomarker, and its expression levels may help determine the balance of eosinophilic and neutrophilic asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Arizona Internship, Basis Tucson North, Tucson, Ariz.
- Department of Cellular and Molecular Medicine, University of Arizona, Tucson, Ariz.
- Department of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy, University of California, San Francisco, Calif.
- Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, Ariz.
- Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
- Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Medicine, Division of Genetics, Genomics and Precision Medicine, University of Arizona, Tucson, Ariz. Electron…
Förderung
- NIEHS NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH Library
Zitieren
APA
Li, N. C., Iannuzo, N., Christenson, S. A., Langlais, P. R., Kraft, M., Ledford, J. G., & Li, X. (2024). Investigation of lactotransferrin messenger RNA expression levels as an anti–type 2 asthma biomarker. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2024.05.013
Vancouver
Li NC, Iannuzo N, Christenson SA, Langlais PR, Kraft M, Ledford JG, et al. Investigation of lactotransferrin messenger RNA expression levels as an anti–type 2 asthma biomarker. Journal of Allergy and Clinical Immunology. 2024. doi:10.1016/j.jaci.2024.05.013
BibTeX
@article{Li2024,
author = {Li, Nicholas C and Iannuzo, Natalie and Christenson, Stephanie A and Langlais, Paul R and Kraft, Monica and Ledford, Julie G and Li, Xingnan},
title = {Investigation of lactotransferrin messenger RNA expression levels as an anti–type 2 asthma biomarker},
journal = {Journal of Allergy and Clinical Immunology},
year = {2024},
doi = {10.1016/j.jaci.2024.05.013}
}
EUVIMED